Evolving practices, treatment decisions, and unmet needs in intermediate-stage hepatocellular carcinoma: An Asia Pacific perspective

Table 1 Hepatocellular carcinoma staging as defined throughout the survey[3,16]

	BCLC stage	Definition
Early HCC	BCLC-0	Single ≤ 2 cm lesion; preserved liver function; ECOG PS 0
	BCLC-A	Single or ≤ 3 nodules, each ≤ 3 cm; preserved liver function; ECOG PS 0
Intermediate HCC	BCLC-B1	Meets extended liver transplant criteria of institution; CPS 5-7; ECOG PS 0; ‘Up to 7’ in
	BCLC-B2	Well-defined nodules, preserved portal flow, selective access; CPS 5-7; ECOG PS 0; ‘Up to 7’ out
	BCLC-B3	Diffuse, infiltrative, extensive bilobar liver involvement; CPS 7; ECOG PS 0; ‘Up to 7’ out
Advanced HCC	BCLC-C	Vascular invasion and/or extrahepatic spread; preserved liver function; ECOG PS 1-2
End-stage HCC	BCLC-D	Any tumour burden; end-stage liver function; ECOG PS 3-4

BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; ECOG PS: Eastern Cooperative Oncology Group performance status; CPS: Child-Pugh score.